Related Experiment Video
Updated: Apr 29, 2026

13:47
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
19.0K
Multivalent comb-type aptamer-siRNA conjugates for efficient and selective intracellular delivery.
Hyundong Yoo1, Hyosook Jung, Seung An Kim
1Department of Bioscience and Biotechnology, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-701, Republic of Korea. hjmok@konkuk.ac.kr.
Summary
Researchers developed a novel method for targeted RNA therapeutic delivery into cancer cells. This strategy uses complementary base pairing for precise intracellular transport, enhancing treatment specificity.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Therapeutics
Background:
- RNA therapeutics offer promising treatment avenues but face challenges in selective delivery.
- Targeting specific cancer cells is crucial to minimize off-target effects and enhance efficacy.
- Current delivery methods often lack the precision required for effective intracellular transport.
Purpose of the Study:
- To design a simple and efficient strategy for selective intracellular delivery of RNA therapeutics.
- To achieve precise delivery into target cancer cells using complementary base pairing.
- To enhance the specificity and efficacy of RNA-based cancer treatments.
Main Methods:
- Chemically conjugated multimeric antisense strands were synthesized.
- Aptamer-incorporating sense strands were designed.
- Direct complementary base pairing was utilized to link antisense and sense strands for targeted delivery.
Main Results:
- The strategy demonstrated selective intracellular delivery of RNA therapeutics.
- Complementary base pairing facilitated efficient and targeted transport into cancer cells.
- The approach showed potential for enhanced specificity in RNA therapeutic delivery.
Conclusions:
- A novel and effective strategy for targeted intracellular delivery of RNA therapeutics was established.
- The method leverages complementary base pairing for precise cancer cell targeting.
- This approach holds significant promise for advancing RNA-based cancer therapies.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
159
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
159

